SCHEMBL29469665

SCHEMBL29469665

CC(C)Oc1ccccc1S(=O)(=O)NC(=O)c1cc2c(F)cc(N3CC(F)C3)cc2o1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 5/20 0.35
ADRA1B P35368 5/20 0.35
DRD2 P14416 4/20 0.35
ADRA1D P25100 4/20 0.35
GAA P10253 1/20 0.35
KAT6A Q92794 4/20 0.34
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
PTGER4 P35408 1/20 0.33
PTGDR Q13258 1/20 0.33
MMP2 P08253 1/20 0.32
MMP14 P50281 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29469810 0.90 MAPT (0.34) ADRA1AADRA1BDRD2ADRA1DGAA
SCHEMBL24334009 0.90 MAPT (0.34) ADRA1AADRA1BDRD2ADRA1DGAA
SCHEMBL24334437 0.90 KMT2A (0.38) ADRA1AADRA1BDRD2ADRA1DGAA
SCHEMBL24334436 0.84 ADRA1A (0.35) ADRA1AADRA1BDRD2ADRA1DKAT6A
SCHEMBL24333606 0.84 CA12 (0.31) MEN1KMT2A
SCHEMBL29469655 0.84 CA12 (0.31) MEN1KMT2A
SCHEMBL24334327 0.82 KEAP1 (0.38) GAAMEN1ALDH1A1KMT2A
SCHEMBL24333646 0.82 SLC6A9 (0.36) GAAMEN1ALDH1A1MAPTMAPK1
SCHEMBL22588110 0.81 GAA (0.38) GAAKAT6AMEN1ALDH1A1MAPT
SCHEMBL31525463 0.80 KAT6A (0.41) DRD2GAAKAT6AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed